Pharmaceutical compositions that comprise inhibitors of neutral Endopeptidase (NEP), producer of endogenous Endothelin System inhibitors and antagonists of angiotensin receptor 1 (AT1)

摘要

A New Combination therapy is described for Cardiovascular Diseases, including hypertension, pulmonary hypertension, congestive heart failure and / or administering a synergistic combination of at least one inhibitor of neutral Endopeptidase Inhibitor, at least one of the S Producer of endogenous Endothelin system and at least an antagonist of the AT1 receptor.Kit comprising such Therapy.